Stocksigma LogoStocksigma Logo

Platinum Industries Targets 35% CAGR by FY29 Amid Global Expansion and Diversification

Platinum Industries reported consolidated Q2FY27 revenue of ₹1,212.7 Mn, up 23.3% YoY, while EBITDA stood at ₹108.3 Mn with an 8.9% margin and PAT at ₹76.0

Platinum Industries Targets 35% CAGR by FY29 Amid Global Expansion and Diversification

Platinum Industries Ltd · Investor Presentation · 05 Nov 2026, 8:32 pm

Platinum Industries Targets 35% CAGR by FY29 Amid Global Expansion and Diversification Platinum Industries reported consolidated Q2FY27 revenue of ₹1,212.7 Mn, up 23.3% YoY, while EBITDA stood at ₹108.3 Mn with an 8.9% margin and PAT at ₹76.0 Mn. For H1FY27, revenue reached ₹2,302.0 Mn, up 7.7% YoY. The company targets a 35% revenue CAGR between FY26 and FY29, supported by fully operational domestic capacity of 60,000 TPA at Palghar and an upcoming 60,000 MTPA greenfield plant in Egypt by Q4FY27. Additionally, subsidiary Rivadu Lifesciences signed an exclusive India partnership on 28th Sep'26 with Korea's CAREGEN for Korglutide.

Original exchange filing (PDF)

More announcements from Platinum Industries Ltd

All Platinum Industries Ltd announcements